Actively Recruiting
Developing a Blood Test to Replace Bone Marrow Evaluation for Diagnosing and Assessing Cytopenia and MDS in Adults
Led by Weizmann Institute of Science · Updated on 2026-03-25
1500
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multi-center observational study to develop a new, less invasive diagnostic tool for myelodysplastic syndromes MDS using peripheral blood samples. The study focuses on profiling circulating hematopoietic stem and progenitor cells cHSPCs with single-cell RNA and DNA sequencing. This approach aims to offer an alternative to the current bone marrow biopsy, which can be invasive and sometimes inconclusive, especially in early or low-risk cases. In this study, patients with unexplained low blood counts or suspected MDS who are referred for bone marrow evaluation will have peripheral blood collected for genomic profiling. The blood samples will be analyzed at the Weizmann Institute of Science using the PERIBLOOD-MDS diagnostic technology. The results from this blood test will be compared to the conventional bone marrow diagnosis to validate its accuracy. No interventions or treatments are given as part of this study. Participants will undergo peripheral blood sampling and standard bone marrow evaluation as part of their usual care. Researchers will collect and compare diagnostic data, blast counts, and karyotype from both tests. The primary outcome is to develop and validate the PERIBLOOD-MDS blood test within three months after sample collection. The study will also assess the tests potential to stratify MDS risk and reduce the need for bone marrow biopsies. Participation may last until the diagnostic data are fully analyzed and compared.
CONDITIONS
Brief Title
Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients
Research Team
C
Clinical Trial Manage
L
Liran Shlush, Prof.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here